Singapore, 22 September 2025 – Actxa, a Singapore-based deep tech company, today announced that the Core Smart Ring, its first smart ring under the Core series, will be officially available for purchase in Singapore from 22 September 2025. Retailing at SGD 349 , the ring comes in Matt Black and Matt White, offering a featherlight, minimalist wearable designed as a wellness and lifestyle companion that fits seamlessly into everyday life. The Core Smart Ring syncs effortlessly with the Actxa App and Healthy 365 mobile app, giving users clear, intuitive access to their health and lifestyle insights — all subscription free . “In a world overflowing with data, we believe health should feel human — intuitive, empowering, and always within reach. The Core Smart Ring is our first step in bringing this belief to life. More than just technology, it is a gentle companion that fits naturally into daily life, quietly guiding you to stay connected with your body. With Core, we are shaping a future where everyone can embrace healthier living,” said Marcus Soo, Chief Executive Officer of Actxa . Key Features of the Core Smart Ring Healthy 365 Integration : Seamlessly syncs with the Healthy 365 mobile app, allowing Singapore users not just to track steps, but also join challenges and be rewarded with Healthpoints. Activity & Movement Insights : Tracks meaningful movement through Intensity Minutes, focusing on activities that benefit heart, body and mind. All-day SpO2 Monitoring : Tracks oxygen saturation levels to support energy and cognitive well-being. Smarter Sleep Tracking : Monitors sleep stages and quality to help you understand nightly recovery. Heart Rate Variability (HRV) and Stress Monitoring : Provides continuous HRV tracking and insights into stress and recovery through heart rate variability (HRV). Meaningful Movement with Intensity Minutes : Track meaningful movement with focus on Moderate to Vigorous Physical Activity that truly benefits your heart, body and mind. VO2 Max & Fitness Age : Estimates VO2 Max and calculates your Fitness Age for a clearer picture of cardiovascular fitness. Choose A Mode That Fits You : Select Standard Mode for balanced monitoring and extended battery life or switch to Enhanced Mode for higher frequency tracking when performance matters. Triple Temperature Sensor Array : Detects thermal trends that may reflect changes in recovery, immunity, or overall wellness. Availability The Core Smart Ring is available for purchase in Singapore from 22 September 2025 at SGD 349 via the Actxa website ( www.actxa.com ) , Lazada , and Shopee . *Weight varies by ring size. Download our Annex and Fact Sheet ---------------------------------------------------------------------------------------------------- For further information, please contact: Tan Lay Eng Communications Manager layeng.tan@actxa.com +65 9877 0406  Hasyimah Begum AJ Communications Executive hasyimah.aj@actxa.com +65 8780 3620   About Actxa Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next-generation preventive healthcare solutions. We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring. To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension. Learn more about Actxa at www.actxa.com .

Commemorating YMCA’s 123rd anniversary and Singapore’s SG60 through a 123km inclusive walk   Singapore, 17 October 2025 – Actxa is privileged to support the YMCA of Singapore’s (“YMCA”) Find Your Y: Inclusive Challenge on 16 October 2025 as the Official Smart-Tech Wearable Sponsor , reinforcing a shared commitment to inclusivity and community.    The Challenge marked YMCA’s 123rd anniversary and Singapore’s SG60 with a 123km inclusive walk across Singapore. Participants, including youth with special needs, caregivers, YMCA staff, volunteers and corporate partners, completed the journey while symbolically tracing “SG60” on the route via GPS mapping.  As the Official Smart-Tech Wearable Sponsor, Actxa provided every participant with a Spark+ Series 2 Activity Tracker  to track their steps and celebrate their progress throughout the journey. In addition, Sense 2 Smart Scales  were sponsored as lucky draw prizes, adding an element of motivation and fun to the event.  “At Actxa, we believe technology should empower people to live healthier and more connected lives,” Marcus Soo, Chief Executive Officer of Actxa .   “The Find Your Y: Inclusive Challenge  reflects our core values of altruism, empathy, and inclusiveness. By walking together and supporting one another, participants demonstrate how purposeful connections and mindful living can strengthen both individuals and the wider community. We are privileged to partner with YMCA in building a more connected and compassionate Singapore.”  YMCA, the organiser of the event, shared that the Challenge was about much more than the distance covered.  “Actxa's support adds a meaningful dimension to this year’s YMCA Inclusive Challenge. With the Sense 2 and Spark+ Series 2 devices, participants can not only track their fitness but also see how every step contributes to a more inclusive community,” said Wu Mei Ling, General Secretary & CEO, YMCA of Singapore.       For further information, please contact:   Tan Lay Eng Communications Manager Actxa Pte Ltd layeng.tan@actxa.com +65 9877 0406   Audrey Low  Marketing & Corporate Communications YMCA of Singapore  audreylow@ymca.org.sg   +65 8288 1303  Hasyimah Begum AJ Communications Executive Actxa Pte Ltd hasyimah.aj@actxa.com +65 8780 3620    Agnes Chai  Marketing & Corporate Communications   YMCA of Singapore  agneschai@ymca.org.sg   +65 9146 9884    About Actxa   Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next-generation preventive healthcare solutions.  We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring.    To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.     Learn more about Actxa at www.actxa.com .    About YMCA of Singapore   The YMCA of Singapore, founded in 1902, is a registered charity that seeks to serve and impact all members of the community regardless of race, language or religion. We champion, challenge and train youth with special needs, youth-at-risk, youth volunteers and leaders to become independent and effective contributors to society. Through our wholistic care and educational programmes, we support children to reach their maximum potential and nurture in them values of care, honesty and responsibility. Beyond the shores of Singapore, we uplift communities through addressing basic needs and engaging in sustainable projects. All these are made possible through the dedicated efforts of volunteers and staff, with the support of stakeholders, funders, donors and our social enterprises.       In 2022, YMCA was conferred the Charity Transparency Award (CTA) by the Charity Council for good disclosure practices.      About YMCA Programmes    YMCA Youth Support conducts various programmes to empower youth with special needs and youth-at-risk. These initiatives enhance the social development of young people, providing them with opportunities for gainful employment and independent living.        Out-of-school youth and youth-at-risk are trained for employability in areas such as early childhood and digital marketing through the YMCA Vocational and Soft Skills Programme. Effective communication, conflict management and resume writing are included in the training for job readiness.       To support their social development, youth with special needs, especially those who are 18 years and above, take part in YMCA Club LITE activities. These range from arts and crafts, sports and fitness, workshops to promote independent living, and more.       YMCA Community Engagement and Partnerships engages donors and volunteers through meaningful fundraising events and volunteering opportunities, to develop youth and impact communities.

Singapore, 23 October 2025  -  Actxa is excited to participate in TechInnovation 2025, Asia’s premier platform for innovation and business transformation, organised by IPI Singapore, where we will showcase BGEM, our AI-driven, non-invasive blood glucose prediction technology that advances the frontier of preventive health innovation. BGEM leverages AI to predict the risk of diabetes and estimate blood glucose levels non-invasively, empowering individuals with actionable health insights that enable proactive lifestyle changes and support long-term well-being. This technology reflects Actxa’s commitment to developing science-based solutions that make preventive health accessible and effective everyday. Learn how Actxa’s AI-driven BGEM technology is shaping the future of preventive health.   Speaker Session   Topic: BGEM: AI for diabetic risk screening and control  Speaker: Dr. Du Yao, Head of Research and Development, Actxa  Date and Time: 30 Oct, Thursday at 3.30pm  Event Details   Date: 29 – 31 October 2025  Location: Sands Expo & Convention Centre, Level 3, Heliconia Ballroom  Stand: K02 Visit our stand to learn more about BGEM and connect with our team to explore how Actxa is shaping the future of preventive health through innovation.   Keen to speak with our team and explore collaboration opportunities? Secure your meeting slot https://forms.office.com/r/qhTpjtSQed

(Media Source: NXT) The future of personal wellness is here, and it fits on your finger. Meet the Core Smart Ring, a cutting-edge health wearable that reimagines how you understand your body. Sleek, lightweight, and packed with intelligent sensors, Core isn’t just a smart ring — it’s a silent partner in your everyday journey to better health. Crafted from aerospace-grade titanium, the Core Smart Ring combines strength, style, and seamless comfort. Whether you’re at work, at rest, or in motion, it delivers deep wellness insights discreetly and continuously. A Smarter Way to Know Yourself From heart rate variability to diabetic risk, the Core Smart Ring monitors vital indicators around the clock to offer a fuller picture of your health. It listens to your body, helping you reconnect with it — gently, intuitively, and in real time. With support across four key areas: Activity, Health, Sleep, and Wellness. Core empowers you to make informed decisions and build sustainable habits. What Sets Core Apart? 1. Non-Invasive Diabetic Risk Detection Powered by proprietary BGEM AI technology, Core identifies early signs of diabetic risk through biometric pattern analysis, giving you clarity and control between medical checkups. 2. Continuous SpO₂ Monitoring Track your oxygen saturation levels throughout the day and night to ensure your body is fuelled, energised, and resilient. 3. Movement That Matters With Intensity Minutes tracking, Core goes beyond counting steps to monitor the effort and cardiovascular impact of your activities, from brisk walks to intense workouts. 4. Advanced Temperature Sensing A Triple Sensor Array captures subtle thermal shifts, helping you spot changes in immunity, recovery, or hormonal balance. 5. VO₂ Max and Fitness Age Understand your aerobic fitness with lab-level metrics, now available at your fingertips. Use your personalised Fitness Age to guide and refine your wellness goals. 6. Smarter Sleep, Deeper Rest Core breaks down your sleep stages and patterns to show how well you’re truly recovering so you can rest better and rise stronger. 7. All-Day HRV and Stress Balance Track your Heart Rate Variability around the clock — a powerful indicator of your body’s resilience and readiness. The Core Smart Ring helps you interpret these subtle shifts to optimise your stress response and performance. Designed to Be Worn, Not Noticed Despite its advanced capabilities, Core is ultra-light (just 2.5g to 3.3g depending on ring size) and only 2.2mm thick. It’s available in Matte Black and Matte Silver, complementing every style while offering 5ATM water resistance, up to 5 days of battery life, and magnetic charging for effortless everyday use. Available in sizes 6 to 14, the Core Smart Ring is built to fit comfortably and securely for all-day wear. Ready to Own Your Well-Being? With a seamless mobile app experience, Core connects via Bluetooth Low Energy and is compatible with both Android (7.0+) and iOS (13.4+). The ring comes with a charging case, USB-C cable, and user guide, everything you need to start your wellness journey. The official launch is in late August 2025, retailing at SGD$349 (incl. GST). Find out more here . Update: The BGEM Diabetic Risk Assessment feature is not available in Singapore, as it is pending clearance from the regulatory authority. It is available only in selected countries/regions.​

The Actxa Core will go on sale late August 2025 for S$349 (Media Source: Hardware Zone) We don’t cover Actxa often enough here. Along with another similar-sounding local brand—Axtro—they’ve traditionally provided the fitness trackers that were part of the Health Promotion Board’s National Steps Challenge programme over the years. If you’ve ever taken part, used the Healthy 365 app and collected the free fitness tracker, you’ve likely used an Actxa product before. They are lesser known outside of this, and the brand’s last product, the Spark+ Series 2 activity tracke r, came out in 2023. So, it was a little surprising to see Actxa pop up in my mailbox this week with a brand new smart ring, and it actually looks like a flagship-level product, unlike the brand’s previous budget-oriented offerings. The Actxa Core smart ring features a super-sleek aerospace-grade titanium build, is ultra-sleek at just 2.2mm thin and practically feather-weight at 2.5g-3.3g (depending on ring size). You get all the usual tracking capabilities like all-day SP02 monitoring , heart rate variability (HRV) and stress , advanced sleep monitoring , and a triple temperature sensor array . What’s unique about the Core smart ring is integration of Actxa’s own proprietary technology called BGEM , which is a clinically proven, AI-driven, non-invasive technology that can help detect early diabetic risk . It also features Moderate to Vigorous Physical Activity (MVPA) tracking with Intensity Minutes , and supposedly recognises daily activity progression. The ring features a LiPo battery that can up to 5-days of use and 5 ATM water resistance. The Actxa Core smart ring will be priced as S$349, launching late August 2025 . What's in the box Update: The BGEM Diabetic Risk Assessment feature is not available in Singapore, as it is pending clearance from the regulatory authority. It is available only in selected countries/regions.​

(Media Source: Trevor Tan) If you are wearing a free fitness tracker from HPB to use with the Health 365 app, there is a high chance it is an Actxa fitness tracker. The Singapore-based deep tech company (as it called itself) will be launching its first-ever smart ring, the Core Smart Ring. Said to be crafted from aerospace-grade titanium, the Core Smart Ring features a minimalist design in two colours of black and silver. At just 8mm wide, 2.2mm thin, it tips the scales from 2.5g to 3.3g (depending on the ring size) and comes with 5ATM water resistance. The smart ring tracks your health by what Actxa described as four pillars of health – Activity, Health, Sleep and Wellness. The Core Smart Ring is available in black and silver. (Photo: Actxa Pte Ltd) However, the key highlight of Core Smart Ring is its ability to detect diabetic risks early with BGEM – a Actxa-proprietary non-invasive glucose monitoring system powering by artificial intelligence. If this works as advertised, this will be a game changer for the entire tech and health industry. Other features of Core Smart Ring include the usual tracking of physical activities, sleep as well as all-day SpO2, heart-rate variability (HRV), VO2 Max and stress level monitoring. It can store up to 7 days of activity data with an estimated battery life of 5 days. What you will be getting out of the box. (Photo: Actxa Pte Ltd) The Core Smart Ring will be available in Singapore from late August 2025 and retails at S$349. For more information, you can visit Actxa . Update: The BGEM Diabetic Risk Assessment feature is not available in Singapore, as it is pending clearance from the regulatory authority. It is available only in selected countries/regions.​

(Media Source: Lianhe Zaobao) 本地保健科技品牌Actxa推出首款智能戒指 Core Smart Ring，以简约设计与轻盈钛合金打造，适合全天佩戴。 这款智能戒指具备多项保健功能，帮助监测休息品质，包括追踪睡眠不同阶段，提供全天血氧监测，心率变异与压力侦测及三重温度感应，以侦测体温细微变化，反映免疫、恢复或荷尔蒙情况。它也能评估糖尿病风险，追踪最大摄氧量（VO2 Max），测量心肺健康，并智能记录运动强度。 此戒指可与Actxa手机应用软件无缝连接，提供全方位健康记录，有哑光黑（matt black）与哑光银（matt silver）两种颜色选择。该产品将于9月中正式推出，并在9月3日至14日于Lazada LazMall抢先举行特别预购活动。 售价：$349（预购活动优惠价$299） 售于：Actxa官网（ actxa.com ）、Shopee和Lazada Update: The BGEM Diabetic Risk Assessment feature is not available in Singapore, as it is pending clearance from the regulatory authority. It is available only in selected countries/regions.​

A local study shows that sensors commonly found in wearables can aid in the non-invasive detection of elevated blood glucose levels (Image source: Stock image) Singapore, 10 October 2024  – Imagine detecting the risk of diabetes with a wearable device, allowing for early intervention through positive lifestyle changes to delay or even prevent the development of this chronic disease.  Type 2 diabetes mellitus (T2DM) is a global non-communicable disease, with cases surging from 108 million in 1980 to 422 million in 2014[1]. Recognising the importance of early detection and intervention, Actxa Pte Ltd (Actxa) partnered with KK Women’s and Children’s Hospital (KKH) on a research study.   This study, “ Utility of photoplethysmography in detecting elevated blood glucose among non-diabetics” , recently published in the Singapore Medical Journal, shows that using photoplethysmography (PPG) signals (the green or red light on most wearables that measure heart rate), a non-invasive method of assessing T2DM risk, is a viable option to provide a more cost-effective and more accessible modality for screening in the community. The full study can be accessed here .      From October 2021 to February 2023, healthy volunteers were recruited at KKH. 483 volunteers’ capillary glucose levels were measured alongside PPG signals using Actxa’s Spark + Series 2 activity tracker and an in-ear wearable. The volunteers were evaluated over eight minutes to obtain accurate PPG readings.     Participants with capillary glucose levels of 11.1 mmol/dL or less consumed a standard glucose tolerance drink (TRUTOL. 75 g) and returned one hour later for a follow-up test. In contrast, those with readings exceeding 11.1 mmol/dL were exempted from the glucose tolerance drink. This methodology ensured the thorough evaluation of blood glucose levels, thereby enhancing the reliability of the study’s findings.    This research leverages the innovative use of PPG sensors to monitor and evaluate increased blood glucose levels non-invasively. The study has revealed that non-invasive diabetes risk assessment using PPG is a practical and cost-effective method for population-wide screening. This non-invasive nature of the PPG approach makes it accessible, encouraging early detection and allowing individuals to adopt timely positive lifestyle changes and seek medical interventions before more severe complications develop.    This study has also demonstrated the capabilities of Actxa’s BGEM technology , the world’s first non-invasive diabetes risk assessment powered by an AI-driven algorithm. BGEM is a cloud-based technology that can be seamlessly integrated into wearable devices with PPG sensors to assess diabetic risk.      As countries grapple with rising healthcare costs related to diabetes care, this technology can potentially reduce long-term healthcare burden by focusing on prevention. Early detection enables individuals to make lifestyle changes that can prevent or delay the onset of T2DM, ultimately leading to healthier populations and more sustainable healthcare systems.    Marcus Soo, Chief Executive Officer of Actxa, said , “In our pursuit of innovative solutions to address global health challenges, Actxa is proud that our technology has been validated through a local study. We are on track to reveal a transformative breakthrough in how we evaluate prediabetes and T2DM risk using PPG sensors.     Actxa’s BGEM technology, which integrates into wearables with PPG sensors, offers a cost-effective and scalable method for non-invasive blood glucose risk assessment, positioning us at the forefront of preventive health technology.     The opportunities here are paradigm-shifting—a wearable device on your wrist, finger, or ear could detect early diabetes risks, enabling individuals to make proactive lifestyle changes. This collaboration reflects our commitment to pushing preventive healthcare innovation, making early detection and prevention accessible for all. Together with our partners, we are charting the course towards a healthier future for individuals and our communities.”    Future developments will involve incorporating various non-invasive detection sensors to enhance sensitivity and specificity, enabling better management of T2DM through non-invasive methods alongside capillary glucose measurements.   Reference:   1. WHO Factsheet on Diabetes: https://www.who.int/news-room/fact-sheets/detail/diabetes     For further information, please contact:   ​Tan Lay Eng   Communications Manager  layeng.tan@actxa.com   +65 9877 0406  Hasyimah Begum AJ  Communications Executive  hasyimah.aj@actxa.com   +65 8780 3620   About Actxa   Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next generation preventive healthcare solutions. ​  We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring. ​​   To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.​​     ​Learn more about Actxa at www.actxa.com .

Singapore, 17 October 2024  —Actxa Pte Ltd, a Singapore-based deep tech company, introduces its BGEM technology . Powered by a cloud-based AI-driven algorithm, BGEM offers a non-invasive solution to assess diabetic risk, marking a new approach to early intervention to delay or prevent the onset of Type 2 diabetes mellitus (T2DM). Diabetes: A Growing Concern In Singapore, it is projected that by 2050, at least 1 million people will be living with diabetes, with 1 out of 4 remaining undiagnosed¹. Globally, the number of diabetic individuals is expected to reach about 643 million by 2030, with 1 in 2 adults undiagnosed². Undiagnosed diabetes poses severe risks, as early-stage symptoms are often silent, leading to delayed diagnosis and potentially irreversible complications. Regular glucose monitoring is essential for detecting the risk of diabetes early, which enables timely and life-saving interventions. A Non-Invasive Approach to Assess Diabetic Risk BGEM leverages advanced photoplethysmography (PPG) sensors to offer a non-invasive solution . By integrating this technology into wearables, BGEM allows users to assess their diabetic risk regularly. This could support and promote early intervention, leading to better health outcomes while reducing long-term pain and cost for individuals.  A joint study by Actxa and KK Women’s and Children’s Hospital (“KKH”), titled   “Utility of photoplethysmography in detecting elevated blood glucose among non-diabetics” and published in the Singapore Medical Journal, validates the effectiveness of PPG sensors in its non-invasive blood glucose detection. The study highlights BGEM’s capabilities in integrating wearable devices with PPG sensors to assess for diabetic risk assessment . The full study can be accessed here .   BGEM leverages wearables with PPG sensors to collect essential data, in which an AI model computes the relevant digital biomarkers correlated with prediabetes or Type 2 Diabetes Mellitus (T2DM) to assess diabetic risk to support early intervention. [Image Source: Actxa] Clinical Validation and Global Partnerships BGEM underwent its first clinical trials in 2022, with its first scientific paper published in 2023. The technology has garnered attention for its potential in monitoring diabetic risk . Actxa continues to collaborate with international partners to explore the broader potential of BGEM, bringing it to markets globally while remaining committed to advancing local innovations in Singapore. Alleviating Financial Strain Through Diabetes Prevention With diabetes on the rise globally, the focus is shifting from reactive treatment to proactive prevention. BGEM’s early detection capabilities enable individuals to make lifestyle changes that can prevent or delay the onset of Type 2 diabetes mellitus (T2DM). By reducing the burden of long-term diabetes management, BGEM contributes to healthier populations and more sustainable healthcare systems. In Singapore, the healthcare system faces significant strain due to the rising number of diabetes cases, with around $940 million spent on diabetes-related care in 2017³. By enabling earlier detection and intervention, BGEM has the potential to ease this burden, contributing to more sustainable healthcare outcomes. Innovating for a Healthier Future Marcus Soo, Chief Executive Officer of Actxa, said , “As a company with a vision to help people live healthier and longer lives through technology, we are dedicated to translating technological innovations into evident solutions that enhance lives. BGEM simplifies the monitoring process, allowing users to gain insights into their health regularly and non-invasively. By continuing to collaborate with partners and refine our technology, we hope to empower more individuals to manage their health proactively. We believe this can lead to better outcomes and support the sustainability of healthcare systems.” Actxa is committed to improving the lives of those affected by diabetes through cutting-edge technology and meaningful collaborations. References: https://www.healthhub.sg/live-healthy/1273/d-day-for-diabetes https://idf.org/aboutdiabetes/what-is-diabetes/factsfigures.html#:~:text=The%20total%20number%20of%20people,living%20with%20dia   betes%20are%20undiagnosed   https://www.moh.gov.sg/news-highlights/details/percentage-of-spending-on-mental-health-diabetes-and-ageing-versus-total-healthcare-spending-in-2018-against-amount-budgeted-for-2019/   For further information, please contact:   ​Tan Lay Eng   Communications Manager  layeng.tan@actxa.com   +65 9877 0406  Hasyimah Begum AJ  Communications Executive  hasyimah.aj@actxa.com   +65 8780 3620   About Actxa   Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next generation preventive healthcare solutions. ​  We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring. ​​   To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.​​     ​Learn more about Actxa at www.actxa.com .

4 April 2024   – Actxa Pte Ltd (“Actxa”), an AI-driven deep tech company headquartered in Singapore, has signed a Memorandum of Agreement (“MOU”) with Instytut Medycyny Innowacyjnej sp.z o.o. (“IMI”), a research and medical technologies institute based in Poland on 7 March 2024. This MOU marks the beginning of a strategic partnership for collaboration and market distribution of Actxa’s BGEM, a non-invasive diabetes risk assessment solution   and other Actxa technologies in Poland. At the heart of this partnership is Actxa’s groundbreaking BGEM technology - the world’s first non-invasive solution for diabetic risk assessment . Harnessing the power of artificial intelligence ("AI"), wearable technologies and signal processing, BGEM tracks and identifies diabetes risk.     By analysing inter-beat-interval data from consumer-grade wearables equipped with photoplethysmography ("PPG") sensors, BGEM calculates the digital biomarkers associated with prediabetes or Type 2 diabetes mellitus ("T2DM") symptoms, empowering users to monitor, track, and identify their diabetic risk . This proactive approach allows users to implement timely lifestyle adjustments, effectively mitigating the risk or delaying the onset of diabetes.    Under this partnership, IMI will be an authorised licensee with the rights to use BGEM and incorporate the technology in its brand of wearable products for distribution in Poland. Additionally, IMI will play a pivotal role in facilitating the exploration of opportunities within countries, governments and industries to sell and market wearables with BGEM and other Actxa technologies.   Marcus Soo, Chief Executive Officer of Actxa , said, “Our collaboration with IMI signifies an important milestone in our journey toward global expansion. This collaboration is a testament to our commitment to innovation and excellence in the tech industry. Together with IMI, we embark on a transformative endeavour, combining our strengths to propel our business to new heights internationally.   This alliance not only strengthens our position in the global market but also allows our technologies, such as BGEM, to benefit a broader community. As we join forces with IMI, we are poised for unparalleled growth, setting the stage for a future defined by international success and groundbreaking achievements.”    Founder of IMI, Professor Mieczysław Pasowicz  shared, “At IMI, we are driven by a shared vision for a future where healthcare is transformed through innovation. Our collaboration with Actxa speaks to our unwavering dedication as we bring their groundbreaking technologies to Poland. Our strategic partnership aims to revolutionise healthcare, fostering a future where cutting-edge solutions positively impact lives. This partnership represents a significant stride towards a healthier and more technologically advanced world.” This alliance between Actxa and IMI sets the stage for Actxa’s innovative technologies to expand globally. As both companies continue to leverage their strengths and expertise, they are poised to drive positive change and contribute to the advancement of a healthier world.  For further information, please contact: ​Tan Lay Eng Communications Manager layeng.tan@actxa.com +65 9877 0406 Hasyimah Begum AJ Communications Executive hasyimah.aj@actxa.com +65 8780 3620  About Actxa Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next generation preventive healthcare solutions. ​ We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring. ​​ To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.​​ ​Learn more about Actxa at www.actxa.com . About Instytut Medycyny Innowacyjnej sp.z o.o   For nearly 30 years Prof. Mieczysław Pasowicz has been creating and implementing initiatives related to the adaptation of hospitals to European Union standards through the creation and implementation of innovative investment projects. He specializes in investment and hospital development, healthcare management and training and digital transformation. It promotes the development of personalized medicine, coordinated healthcare and digital medicine. This is possible thanks to the involvement in modern technologies, advanced treatment methods and continuous training of medical personnel. Prof. Mieczysław Pasowicz is the founder and president/CEO of the Institute.  The Institute of Innovative Medicine is a spin-off company established to commercialize research and implement new medical technologies. The company is the initiator of the creation of the BioMedTech Technology Park, the aim of which is to transfer technology from Asia to Europe and is currently looking for Partners and Investors interested in co-creating the Longevity Technology Park using the latest developments in medical robotics,  biotechnology, IT, artificial intelligence and other medical technologies. It already has a modern facility with an area of 18 thousand m2 and an investment area for the creation of the Park ( www.medtechpoland.eu ).   Leading programs promoting organizational, product and technological innovations, the Institute of Innovative Medicine together with its partners achieves better results and market position in many areas. The Institute provides consulting and training services, provides specialized IT systems and medical equipment and offers management of healthcare facilities. It has several medical teams and cooperates with more than 100 specialists both at home and abroad. The Institute and BioMedTech Park will support young companies, innovative products and proven technologies, introducing them to domestic and international markets on behalf of customers and through sales programs.  Prof. Dr hab. med. Mieczysław Pasowicz is a long-time director of the John Paul II Hospital in Krakow and vice-president of the European Association of Hospital Managers (EAHM). He is the founder and also serves as the president of the Polish Association of Hospital Directors. Prof. Pasowicz is a long-term academic lecturer with significant medical, scientific and organizational achievements.

Actxa CEO, Marcus Soo (right) and Dr Abhinav (left) embarking on a new partnership. 10 June 2024   – Actxa Pte Ltd (“Actxa”), a Singaporean AI-driven deep tech company, has entered a Memorandum of Understanding (“MOU”) with the Diabetes and Hypertension Clinic (“DHC”) in India, a diabetes evaluation and management centre. The MOU, signed on 6 June 2024, marks a strategic step for Actxa to further research on diabetes prevention with artificial intelligence (“AI”) in India.   Since 2017, Actxa has been collaborating with research and medical institutions in Singapore in the research and development of non-invasive technology for diabetic risk assessment . The company completed its first clinical trial in 2022 and published its first scientific paper in 2023.  Actxa’s BGEM is the world’s first non-invasive solution powered by an AI-driven algorithm that enables wearables and hearables with Photoplethysmography (PPG) sensors to assess diabetic risk .​   In India, an estimated 77 million people above the age of 18 suffer from T2DM, with nearly 25 million classified as prediabetic [1]. Individuals with diabetes are at a higher risk for serious health issues, including heart attack, stroke and kidney failure. Over time, T2DM can damage blood vessels in the heart, eyes, kidneys and nerves [2].   This MOU seeks to broaden the study of non-invasive solution using artificial intelligence in the Indian population. If successful, the non-invasive solution will be an affordable and user-friendly approach to promoting frequent monitoring of diabetic risk in India . Marcus Soo , Chief Executive Officer of Actxa , said, “We are happy to work with like-minded professionals like Dr. Abhinav Gupta of DHC. This collaboration showcases commitment from both Actxa and DHC, and our dedication to improving the lives of individuals affected by diabetes through innovation and excellence using advanced science and AI technology. Together with DHC, we aim to empower individuals in India with valuable insights into their diabetic health.”   Dr. Abhinav Gupta, MBBS, MD, FRCP, Professor of Medicine at ASCOMS,  shared, “Our collaboration with Actxa represents a pivotal milestone in our journey in advancing diabetes prevention and care.  Through research on AI-based algorithms for detecting hyperglycemia in diabetes patients, we are poised to make significant strides in early detection and treatment. This partnership underscores our dedication to harnessing cutting-edge technology for better health outcomes, aligning with the innovative BGEM technology.”   This collaboration between Actxa and DHC paves the way for groundbreaking advancements in diabetes prevention and care, contributing to a healthier future for individuals in Singapore, India and worldwide.    References: 1. World Health Organization, Diabetes in India: https://www.who.int/india/health-topics/mobile-technology-for-preventing-ncds 2. World Health Organization, Diabetes: https://www.who.int/news-room/fact-sheets/detail/diabetes     For further information, please contact: ​Tan Lay Eng Communications Manager layeng.tan@actxa.com +65 9877 0406 Hasyimah Begum AJ Communications Executive hasyimah.aj@actxa.com +65 8780 3620    About Actxa Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next generation preventive healthcare solutions. ​ We create evidence-based, personalised health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring. ​​ To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.​​   ​Learn more about Actxa at www.actxa.com .   About Diabetes and Hypertension Clinic   Diabetes and Hypertension Clinic is a daycare setting run by Dr. Abhinav Gupta, who is a pioneer in the management of Diabetes and Hypertension. He has more than 15 years of experience in DHC, which is located in Channi Himmat Jammu, J&K, India.   Dr. Gupta has been awarded a fellowship of the Royal College of Physicians of London, Edinburgh and Glasgow.

25 July 2024  – Actxa Pte Ltd (“Actxa”), a Singaporean AI-driven deep tech company, has entered a Memorandum of Understanding (“MOU”) and a Research and Collaboration Agreement (“RCA”) with Universitas Kristen Krida Wacana (“UKRIDA”), a prominent private institution of higher education that has been committed to education, research, and community service for 56 years in Indonesia, with its Faculty of Medicine and Health Sciences being the oldest at the university.     The MOU and RCA, signed on 24 July 2024, mark a significant milestone for Actxa as it embarks on a collaborative partnership focusing on joint research, product development, higher education, human resources development, and community services in artificial intelligence (“AI”) based chronic disease management. UKRIDA, whose mission is to be at the forefront of healthcare science development, has embraced Artificial intelligence as an avant-garde, innovative technology as a major focus for UKRIDA’s Research and Development efforts. This joint project, therefore, will bring great benefit to both Actxa and UKRIDA, whose interests are perfectly matched.     Since 2017, Actxa has been at the forefront of collaborations with research and medical institutions in Singapore and globally, focusing on developing life-changing preventive health technologies and solutions using AI.  One of Actxa’s most significant achievements is BGEM , the world’s first non-invasive solution for diabetic risk assessment . Powered by a cloud-based AI-driven algorithm, BGEM integrates seamlessly with smart wearables and hearables using Photoplethysmography (PPG) sensors to assess diabetic risk .    UKRIDA’s interest in developing healthcare based on innovative technology has found BGEM to have great potential in glucose metabolism evaluation and control, especially since diabetes mellitus is one of the major metabolic diseases that needs to be prevented and controlled. The joint project with Actxa to further develop BGEM capabilities and adapt them to the Indonesian population will enable UKRIDA to be a pioneer in chronic disease prevention and control technology in Indonesia.  ​   This strategic partnership enables Actxa and UKRIDA, with its motto “Lead to Impact”, to jointly pioneer research and development initiatives leveraging cutting-edge technologies such as AI, Machine Learning (“ML”), and Big Data Analytics. Their collaborative efforts aim to detect, delay, or prevent the onset of chronic diseases. This alliance fosters innovation through the co-creation of healthcare solutions and advanced technologies, coupled with rapid prototyping, to accelerate the market introduction of these products and technologies.    Marcus Soo , Chief Executive Officer of Actxa , said, “We are honoured to partner with UKRIDA, marking a significant milestone for Actxa as we embark on our very first collaboration with an Indonesian university conducting research within a hospital setting. This partnership reflects our shared commitment to innovation and empowering individuals with tools to make informed and positive lifestyle decisions.  We extend our gratitude to our joint venture partner, LIF, for their pivotal role in this close partnership, facilitating our efforts in Indonesia. Together, we aim to drive global innovation in preventive healthcare, leveraging our combined expertise to make meaningful strides in chronic disease prevention and management.”  Prof. Dr.-Ing. Ir. Herman Parung, M.Eng, Rector of UKRDIA, shared, “Both Actxa and UKRIDA share a profound commitment to innovation and the advancement of preventive healthcare solutions. This partnership is poised to accelerate the development of advanced healthcare solutions, ultimately contributing to better health and well-being for individuals and communities.” He also added, “We are confident that this partnership will yield significant advancements in healthcare and foster a strong bond between our institutions.”  This partnership between Actxa and UKRIDA heralds groundbreaking innovations in chronic disease prevention and management, working towards building a healthier future for individuals in Singapore, Indonesia, and worldwide. This joint project will also be an example of UKRIDA’s commitment to developing health science based on innovative technology and its effort to build strategic partners from national, regional, and international circles to bring greater progress and benefit to society.  For further information, please contact:     ​Tan Lay Eng  Communications Manager  layeng.tan@actxa.com   +65 9877 0406  Hasyimah Begum AJ  Communications Executive  hasyimah.aj@actxa.com   +65 8780 3620   About Actxa   Headquartered in Singapore, Actxa Pte Ltd is a deep tech company founded in 2015 that leverages artificial intelligence to create next generation preventive healthcare solutions.   We create evidence-based, personalized health insights in the domains of physical activities, sleep quality, body composition, stress and recovery, heart health and blood glucose evaluation and monitoring. ​​  To improve population health, Actxa establishes worldwide partnerships and research collaborations to develop critical preventive health models to help people avert chronic diseases such as diabetes and hypertension.​​  ​Learn more about Actxa at www.actxa.com .